Intermediate hepatocellular carcinoma: current treatments and future perspectives [PDF]
, 2017 Current guidelines recommend transarterial chemoembolization (TACE) as the standard treatment of Barcelona-Clinic Liver Cancer (BCLC)-B patients. However, the long-term survival outcomes of patients managed with this technique do not appear fully ...
Bargellini, I. +5 more
core
Gastroduodenal ulceration following liver radioembolization with yttrium-90 [PDF]
Endoscopy, 2013 N, Veloso +6 more
openaire +2 more sources
Yttrium-90 Radioembolization as the Major Treatment of Hepatocellular Carcinoma. [PDF]
J Hepatocell Carcinoma, 2023 Yu CY +10 more
europepmc +1 more source
Correction: Precision dosimetry in yttrium-90 radioembolization through CT imaging of radiopaque microspheres in a rabbit liver model. [PDF]
EJNMMI Phys, 2023 Henry EC +11 more
europepmc +1 more source
Selective internal radiation therapy of hepatic tumors: procedural implications of a patent hepatic falciform artery [PDF]
, 2014 core +1 more source
Radiation pneumonitis following Yttrium-90 radioembolization: A Korean multicenter study. [PDF]
Front Oncol, 2023 Kim HC, Kim GM.
europepmc +1 more source
Protective Embolization of the Gastroduodenal Artery with a One-HydroCoil Technique in Radioembolization Procedures [PDF]
, 2018 Purpose: Protective occlusion of the gastroduodenal artery (GDA) is required to avoid severe adverse effects and complications in radioembolization procedures.
Ernst, C. +7 more
core
Introduction to Issue on Yttrium-90 Radioembolization [PDF]
Techniques in Vascular and Interventional Radiology, 2019 openaire +2 more sources
Safety and Efficacy of Concurrent Atezolizumab/Bevacizumab or Nivolumab Combination Therapy with Yttrium-90 Radioembolization of Advanced Unresectable Hepatocellular Carcinoma. [PDF]
Curr Oncol, 2023 Villalobos A +7 more
europepmc +1 more source